Foreign-Trade Zone (FTZ) 7-Mayaguez, Puerto Rico; Authorization of Production Activity; AbbVie Ltd. (Pharmaceutical Products), Barceloneta, Puerto Rico, 52444 [2021-20376]
Download as PDF
<![CDATA[
52444
Federal Register / Vol. 86, No. 180 / Tuesday, September 21, 2021 / Notices
All results from the Small Business
Pulse Survey will continue to be
disseminated as U.S. Census Bureau
Experimental Data Products (https://
portal.census.gov/pulse/data/). This and
additional information on the Small
Business Pulse Survey are available to
the public on census.gov.
Affected Public: Business or other forprofit organizations.
Frequency: Small business will be
selected once to participate in a 6minute survey.
Respondent’s Obligation: Voluntary.
Legal Authority: Title 13 U.S.C.,
Sections 131 and 182.
This information collection request
may be viewed at www.reginfo.gov.
Follow the instructions to view the
Department of Commerce collections
currently under review by OMB.
Written comments and
recommendations for the proposed
information collection should be
submitted within 30 days of the
publication of this notice on the
following website www.reginfo.gov/
public/do/PRAMain. Find this
particular information collection by
selecting ‘‘Currently under 30-day
Review—Open for Public Comments’’ or
by using the search function and
entering either the title of the collection
or the OMB Control Number 0607–1014.
Sheleen Dumas,
Department PRA Clearance Officer, Office of
the Chief Information Officer, Commerce
Department.
[FR Doc. 2021–20421 Filed 9–20–21; 8:45 am]
BILLING CODE 3510–07–P
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B–41–2021]
lotter on DSK11XQN23PROD with NOTICES1
Foreign-Trade Zone (FTZ) 7—
Mayaguez, Puerto Rico; Authorization
of Production Activity; AbbVie Ltd.
(Pharmaceutical Products),
Barceloneta, Puerto Rico
On May 19, 2021, AbbVie Ltd.,
submitted a notification of proposed
production activity to the FTZ Board for
its facility within Subzone 7I, in
Barceloneta, Puerto Rico.
The notification was processed in
accordance with the regulations of the
FTZ Board (15 CFR part 400), including
notice in the Federal Register inviting
public comment (86 FR 28540, May 27,
2021). On September 16, 2021, the
applicant was notified of the FTZ
Board’s decision that no further review
of the activity is warranted at this time.
The production activity described in the
VerDate Sep<11>2014
21:03 Sep 20, 2021
Jkt 253001
notification was authorized, subject to
the FTZ Act and the FTZ Board’s
regulations, including Section 400.14.
Dated: September 16, 2021.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2021–20376 Filed 9–20–21; 8:45 am]
BILLING CODE 3510–DS–P
DEPARTMENT OF COMMERCE
International Trade Administration
[A–570–894]
Certain Tissue Paper Products From
the People’s Republic of China: Final
Results of Expedited Sunset Review of
the Antidumping Duty Order
Enforcement and Compliance,
International Trade Administration,
Department of Commerce.
SUMMARY: The Department of Commerce
(Commerce) finds that revocation of the
antidumping duty (AD) order on certain
tissue paper products (tissue paper)
from the People’s Republic of China
(China) would be likely to lead to a
continuation or recurrence of dumping,
at the levels indicated in the ‘‘Final
Results of Sunset Review’’ section of
this notice.
DATES: Applicable September 21, 2021.
FOR FURTHER INFORMATION CONTACT:
Brian Smith, AD/CVD Operations,
Office VIII, Enforcement and
Compliance, International Trade
Administration, U.S. Department of
Commerce, 1401 Constitution Avenue
NW, Washington, DC 20230; telephone:
(202) 482–1766.
SUPPLEMENTARY INFORMATION:
AGENCY:
Background
On March 30, 2005, Commerce
published the antidumping duty order
on tissue paper from China.1 On June 1,
2021, Commerce published the
initiation of the third sunset review of
the Order on tissue paper from China,
pursuant to section 751(c) of the Tariff
Act of 1930, as amended (the Act).2 On
June 11, 2021, Commerce received a
timely and complete notice of intent to
participate in this sunset review from
Seaman Paper Company of
Massachusetts, Inc. (Seaman Paper),
within the deadline specified in 19 CFR
351.218(d)(1)(i).3 Seaman Paper claimed
1 See Notice of Amended Final Determination of
Sales at Less Than Fair Value and Antidumping
Duty Order: Certain Tissue Paper Products from the
People’s Republic of China, 70 FR 16223 (March 30,
2005) (Order).
2 See Initiation of Five-Year (‘‘Sunset’’) Reviews,
86 FR 29239 (June 1, 2021).
3 See Domestic Interested Party’s Letter, ‘‘Certain
Tissue Paper Products from the People’s Republic
PO 00000
Frm 00007
Fmt 4703
Sfmt 4703
interested party status within the
meaning of section 771(9)(C) of the Act
as a U.S. producer of the domestic like
product.4
On July 1, 2021, Seaman Paper filed
a timely and adequate substantive
response, within the deadline specified
in 19 CFR 351.218(d)(3)(i).5 Commerce
did not receive a substantive response
from any respondent interested party.
As a result, pursuant to section
751(c)(3)(B) of the Act and 19 CFR
351.218(e)(1)(ii)(C)(2), Commerce
conducted an expedited (120-day)
sunset review of the Order.
Scope of the Order
The merchandise covered by the
Order is certain tissue paper products
from China. The subject merchandise
may be under one or more of several
different subheadings of the
Harmonized Tariff Schedule of the
United States (HTSUS), including:
4802.30, 4802.54, 4802.61, 4802.62,
4802.69, 4804.31.1000, 4804.31.2000,
4804.31.4020, 4804.31.4040,
4804.31.6000, 4804.39, 4805.91.1090,
4805.91.5000, 4805.91.7000, 4806.40,
4808.30, 4808.90, 4811.90, 4823.90,
4802.50.00, 4802.90.00, 4805.91.90,
9505.90.40. Although HTSUS
subheadings are provided for
convenience and customs purposes, the
written description of the scope is
dispositive.6 A full description of the
scope of the Order is contained in the
accompanying Issues and Decision
Memorandum.7
Analysis of Comments Received
A complete discussion of all issues
raised in this sunset review, including
the likelihood of continuation or
recurrence of dumping in the event of
revocation of the Order and the
magnitude of the margin likely to
prevail if the Order was to be revoked,
is provided in the Issues and Decision
Memorandum. A list of the topics
discussed in the Issues and Decision
of China: Notice of Intent to Participate,’’ dated June
11, 2021.
4 Id.
5 See Domestic Interested Party’s Letter, ‘‘Certain
Tissue Paper Products from the People’s Republic
of China: Substantive Response to Notice of
Initiation,’’ dated July 1, 2021.
6 On January 30, 2007, at the direction of CBP, the
Department added the following HTSUS
classifications to the AD/CVD module for tissue
paper: 4802.54.3100, 4802.54.6100, and
4823.90.6700. However, we note that the six- digit
classifications for these numbers were already listed
in the scope.
7 See Memorandum, ‘‘Issues and Decision
Memorandum for the Final Results of the Expedited
Sunset Review of the Antidumping Duty Order on
Certain Tissue Paper Products from the People’s
Republic of China,’’ dated concurrently with, and
hereby adopted by, this notice (Issues and Decision
Memorandum).
E:\FR\FM\21SEN1.SGM
21SEN1
]]>Agencies
[Federal Register Volume 86, Number 180 (Tuesday, September 21, 2021)]
[Notices]
[Page 52444]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-20376]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B-41-2021]
Foreign-Trade Zone (FTZ) 7--Mayaguez, Puerto Rico; Authorization
of Production Activity; AbbVie Ltd. (Pharmaceutical Products),
Barceloneta, Puerto Rico
On May 19, 2021, AbbVie Ltd., submitted a notification of proposed
production activity to the FTZ Board for its facility within Subzone
7I, in Barceloneta, Puerto Rico.
The notification was processed in accordance with the regulations
of the FTZ Board (15 CFR part 400), including notice in the Federal
Register inviting public comment (86 FR 28540, May 27, 2021). On
September 16, 2021, the applicant was notified of the FTZ Board's
decision that no further review of the activity is warranted at this
time. The production activity described in the notification was
authorized, subject to the FTZ Act and the FTZ Board's regulations,
including Section 400.14.
Dated: September 16, 2021.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2021-20376 Filed 9-20-21; 8:45 am]
BILLING CODE 3510-DS-P
